Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality
Authors
Keywords
-
Journal
PROSTATE
Volume 73, Issue 9, Pages 905-912
Publisher
Wiley
Online
2013-01-18
DOI
10.1002/pros.22636
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
- (2012) A. Pettersson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality
- (2012) Tarek A. Bismar et al. EUROPEAN JOURNAL OF CANCER
- ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies
- (2012) M Braun et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
- (2011) Alcides Chaux et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
- (2011) A Marije Hoogland et al. MODERN PATHOLOGY
- Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas
- (2011) Antoun Toubaji et al. MODERN PATHOLOGY
- ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
- (2010) B Furusato et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
- (2009) K. G. Hermans et al. CLINICAL CANCER RESEARCH
- Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
- (2008) Liesel M FitzGerald et al. BMC CANCER
- Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
- (2008) J. Wang et al. CANCER RESEARCH
- Characterization of TMPRSS2-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
- (2008) R. Mehra et al. CANCER RESEARCH
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
- (2008) O. R. Saramaki et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now